Synthes takeover could be the orthopedics makeover that Johnson & Johnson needs April 20, 2011 By MassDevice staff Leave a Comment MASSDEVICE ON CALL — Johnson & Johnson’s (NYSE:JNJ) may be looking at its proposed mega-merger with Synthes as a way to save its orthopedics business.